Spots Global Cancer Trial Database for naquotinib
Every month we try and update this database with for naquotinib cancer trials from around the world to help patients and their families find trials that might be right for them.
We offer this 100% free of charge and do not endorse any of the trials listed here, we hope it helps you or a loved one.
The following info and data is provided "as is" to help patients around the globe.
We do not endorse or review these studies in any way.
Study title | NCT ID | Conditions | Interventions | Eligibility | Organization | Link |
---|---|---|---|---|---|---|
A Study of ASP8273 in Subjects With Non-small Cell Lung Cancer (NSCLC) Harboring Epidermal Growth Factor Receptor (EGFR) Mutations | NCT03082300 | Non-small Cell ... Epidermal Growt... | naquotinib | 18 Years - | Astellas Pharma Inc | |
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations | NCT02588261 | Non-small Cell ... | naquotinib mesi... Erlotinib Gefitinib | 18 Years - | Astellas Pharma Inc | |
A Study of ASP8273 vs. Erlotinib or Gefitinib in First-line Treatment of Patients With Stage IIIB/IV Non-small Cell Lung Cancer Tumors With EGFR Activating Mutations | NCT02588261 | Non-small Cell ... | naquotinib mesi... Erlotinib Gefitinib | 18 Years - | Astellas Pharma Inc |